PR Newswire
BOSTON, April 20, 2023
BOSTON, April 20, 2023 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, today announced the release of its 2022 Corporate Responsibility Report. The report outlines key environmental, social and governance (ESG) initiatives of Haemonetics that align with its core values and corporate strategy.
Haemonetics' 2022 Corporate Responsibility report provides data for its fiscal year 2022 that ended on April 2, 2022, unless otherwise indicated, and reports on the company's ESG progress across four pillars: "Growing Our Business Responsibly", "Investing in Our People", "Driving Social Impact" and "Reducing Our Environmental Impact." Highlights from the report include:
"As we continue to grow our business, we are guided by our Purpose and mindful of the expectations of our stakeholders whose trust we value," said Christopher A. Simon, Haemonetics' President and Chief Executive Officer. "With our inaugural Corporate Responsibility Report, we are proud to share the steps we are taking to proactively identify and manage ESG risks and opportunities, and to help ensure the long-term health and success of our company, our employees, and the customers and communities we serve."
Haemonetics' 2022 Corporate Responsibility Report is available on the company's website here.
About Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contacts:
Olga Guyette, Sr. Director-Investor Relations & Treasury
(781) 356-9763
olga.guyette@haemonetics.com
David Trenk, Manager-Investor Relations
(203) 733-4987
david.trenk@haemonetics.com
Media Contact:
Josh Gitelson, Director-Global Communications
(781) 356-9776
josh.gitelson@haemonetics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-publishes-inaugural-corporate-responsibility-report-301802894.html
SOURCE Haemonetics Corporation
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.